Orchid Chemicals and Pharmaceuticals of India will exit from its ten-year-old JV with North China Pharma, selling its 50% stake to its partner for $13.9 million. Orchid originally invested $5 million to set up the enterprise. The JV operated a cephalosporin API manufacturing facility in Shijiazhuang, China. More details.... Stock Symbol: (BSE: 524372) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});